Protein clues in pancreatic cancer may predict patient outcomes
NCT ID NCT06705335
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study is looking at certain proteins, called convertases, in pancreatic tumor samples from 50 adults. Researchers want to see if the levels of these proteins are linked to how the immune system reacts to the cancer. The goal is to find new ways to predict how the disease will progress, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Bergonié, Comprehensive Cancer Center
RECRUITINGBordeaux, France
Conditions
Explore the condition pages connected to this study.